Product Description
Discover the trending and first-string choice for pharmaceutical synthesis: 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic Acid (CAS No: 121669-94-7). Known for its classic, highly pure (>98%) form, this top thiazolecarboxylic acid derivative has unbeatable application as an API intermediate. Supplied as a solid, white to off-white powder, it complies with uncompromising quality controls including ICH Q3C and pharmacopeial standards. With multiple packaging options (1 kg, 5 kg, or as required), this pharmaceutical-grade compound represents a deal for exporters, manufacturers, and suppliers focused on achieving optimal results.
Competitive Edge & User Profile
This compound offers classic performance and unbeatable purity, making it a first-string choice for major pharmaceutical companies, research organizations, and chemical manufacturers. Used predominantly as an intermediate in drug synthesis, it provides a reliable backbone in innovative formulations. The trending demand stems from its stable storage profile, high efficacy, and recognized compliance with international quality standards. Its versatility allows usage in both laboratory-scale and industrial-setting processes.
Sample, Packaging & Certification Details
We provide trending sample packs to facilitate quick evaluation and onboarding. All samples and shipments are handed over securely in pharmaceutical-grade packaging, including 1 kg, 5 kg, or custom requirements to suit shipment size. Each lot is shipped with comprehensive documentation and certifications, attesting to quality and compliance. Upon order, goods are shipped promptly, ensuring optimal condition and traceability throughout the supply chain, demonstrating our commitment as a top exporter and manufacturer.
FAQ's of 2-3-cyano-4-isobutoxyphenyl-4-methyl-1-3-thiazole-5-carboxylic Acid:
Q: How is 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic Acid typically used?
A: It is primarily used as an intermediate in pharmaceutical and chemical synthesis, contributing to API development and research.
Q: What competitive advantages does this compound offer compared to alternatives?
A: Its unbeatable purity, compliance with ICH Q3C and pharmacopeial quality controls, and flexible packaging make it the top choice for reliable pharmaceutical synthesis.
Q: When will samples or shipments be handed over after order confirmation?
A: Samples and orders are typically processed and shipped promptly after confirmation, with reliable timelines communicated for transparent tracking.
Q: Where are the manufacturing and shipping operations based?
A: Manufacturing, export, and supply operations are based in India, adhering to international standards for quality and safety.
Q: What should be considered regarding storage and handling for this active pharmaceutical ingredient?
A: This compound should be stored in a cool, dry, and well-ventilated place, in tightly sealed containers, as per MSDS and product guidelines.
Q: What are the key benefits for pharmaceutical manufacturers using this product?
A: Manufacturers benefit from certified quality, high purity, regulatory compliance, and customizable packaging, supporting efficient project execution.